[HTML][HTML] Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis

L Xie, S Wu, R He, S Li, X Lai, Z Wang - Frontiers in Immunology, 2022 - frontiersin.org
Kidney cancer is one the most lethal cancers of the urinary system, but current treatments
are limited and its prognosis is poor. This study focused on kidney renal clear cell carcinoma …

[HTML][HTML] Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis

L Xie, S Wu, R He, S Li, X Lai, Z Wang - Frontiers in Immunology, 2022 - ncbi.nlm.nih.gov
Kidney cancer is one the most lethal cancers of the urinary system, but current treatments
are limited and its prognosis is poor. This study focused on kidney renal clear cell carcinoma …

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis

L Xie, S Wu, R He, S Li, X Lai… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Kidney cancer is one the most lethal cancers of the urinary system, but current treatments
are limited and its prognosis is poor. This study focused on kidney renal clear cell carcinoma …

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis.

L Xie, S Wu, R He, S Li, X Lai, Z Wang - Frontiers in Immunology, 2022 - europepmc.org
Kidney cancer is one the most lethal cancers of the urinary system, but current treatments
are limited and its prognosis is poor. This study focused on kidney renal clear cell carcinoma …

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis.

L Xie, S Wu, R He, S Li, X Lai, Z Wang - Frontiers in Immunology, 2022 - europepmc.org
Kidney cancer is one the most lethal cancers of the urinary system, but current treatments
are limited and its prognosis is poor. This study focused on kidney renal clear cell carcinoma …